Area of research
Cardiology and Cardiovascular Medicine · Biomedical Engineering
Research interest
Research interests include Cardiac Valve Diseases and Treatments, Antiplatelet Therapy and Cardiovascular Diseases, Atrial Fibrillation Management and Outcomes, and Mechanical Circulatory Support Devices.
Predicting Outcomes in Patients With Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair Using an Artificial Intelligence–Derived Risk Score
Applying the 2025 ESC/EACTS Recommendations for the Treatment of Severe Tricuspid Regurgitation to Real-World Practice
Combined transcatheter mitral and tricuspid edge-to-edge repair or tricuspid edge-to-edge repair alone in moderate mitral regurgitation: a propensity-matched analysis
Long-Term Outcomes of the DanGer Shock Trial
Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock
CSWG-SCAI Stages Combined With Machine Learning–Based Phenotypes for Serial Risk Stratification in Cardiogenic Shock
Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiac Implantable Electronic Devices
Casein kinase 1α essentially regulates thrombopoiesis by driving megakaryocyte maturation and cytoskeleton organization
Improved Risk Assessment in Parvovirus B19-Positive Patients with Heart Failure By Multiparametric Analysis of Endomyocardial Biopsy Using Machine Learning Methods
Invasive Hemodynamics and Risk Stratification in T-TEER: Moving Beyond ESC Thresholds - EuroTR Registry Insights
Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock
Treating Older Patients in Cardiogenic Shock With a Microaxial Flow Pump
Real-World Characteristics and Treatment of Cardiac Transthyretin Amyloidosis: A Multicentre, Observational Study
The Clinical Frailty Scale for mortality prediction of old acutely admitted intensive care patients: a meta-analysis of individual patient-level data
Heparin dosing in patients with Impella-supported cardiogenic shock
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock
Neutrophil “plucking” on megakaryocytes drives platelet production and boosts cardiovascular disease